Revenue has fallen sharply from $72.7M in 2025Q2 to $39.5M in 2026Q3 while gross margin recovered to 40.9%, but operating margin remained negative at -6.0% in 2026Q3, suggesting cost normalization has not yet translated into operating profitability.
Amarin Corporation plc (AMRN) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Aug'98 | Aug'97 | Aug'96 |
|---|
| Sales/Revenue | 176.04M | 213.65M | 228.61M | 306.91M | 369.19M | 583.19M | 614.06M | 429.75M | 229.21M | 181.1M | 130.08M | 81.76M | 54.2M | 26.35M | 0 | 0 | 0 | 0 | 0 | 7.37M | 500K | 500K | 1.02M | 7.37M | 65.51M | 4.99M | 15.74M | 11.22M | 10M | 24.3M | 21.5M |
| Revenue Growth % | -22.36% | -6.55% | -25.51% | -16.87% | -36.69% | -5.03% | 42.89% | 87.49% | 26.56% | 39.22% | 59.11% | 50.84% | 105.69% | - | - | - | - | - | -100% | 1373% | 0% | -50.84% | -86.19% | -88.76% | 1211.96% | -68.27% | 40.29% | 12.18% | -58.85% | 13.02% | -26.12% |
| Cost of Goods Sold | 104.67M | 92.78M | 147.23M | 141.37M | 126.71M | 121.33M | 131.44M | 96.02M | 54.54M | 44.95M | 34.36M | 27.88M | 20.48M | 11.91M | 451.33K | 100.43K | 99.97K | 581.82K | 0 | 0 | 0 | 0 | 107K | 11.91M | 30.13M | 21.46M | 4.62M | 2.98M | 3.7M | 2.8M | 4M |
| COGS % of Revenue | - | 43.43% | 64.4% | 46.06% | 34.32% | 20.8% | 21.41% | 22.34% | 23.8% | 24.82% | 26.42% | 34.1% | 37.79% | 45.21% | - | - | - | - | - | - | - | - | 10.52% | 161.74% | 45.99% | 429.72% | 29.35% | 26.53% | 37% | 11.52% | 18.6% |
| Gross Profit | 71.37M | 120.87M | 81.38M | 165.54M | 242.48M | 461.86M | 482.62M | 333.74M | 174.67M | 136.15M | 95.72M | 53.88M | 33.72M | 14.44M | 0 | 0 | 0 | 0 | 0 | 7.37M | 500K | 500K | 910K | -4.55M | 35.38M | 32.32M | 11.12M | 8.24M | 15.3M | 21.5M | 17.5M |
| Gross Margin % | 40.54% | 56.57% | 35.6% | 53.94% | 65.68% | 79.2% | 78.59% | 77.66% | 76.2% | 75.18% | 73.58% | 65.9% | 62.21% | 54.79% | - | - | - | - | - | 100% | 100% | 100% | 89.48% | -61.74% | 54.01% | 647.25% | 70.65% | 73.47% | 153% | 88.48% | 81.4% |
| Gross Profit Growth % | - | 48.52% | -50.84% | -31.73% | -47.5% | -4.3% | 44.61% | 91.07% | 28.29% | 42.24% | 77.65% | 59.8% | 133.51% | - | - | - | - | - | -100% | 1373% | 0% | -45.05% | 120.01% | -112.85% | 9.47% | 190.65% | 34.91% | -46.13% | -28.84% | 22.86% | -27.69% |
| Operating Expenses | 95.97M | 134.81M | 173.18M | 222.16M | 348.35M | 451.36M | 502.27M | 358.01M | 282.9M | 181.71M | 161.35M | 152.1M | 129.67M | 196.54M | 116.75M | 44.16M | 45.1M | 30.93M | 28.18M | 40.73M | 31.13M | 18.76M | 12M | 34.27M | 69.12M | 37.4M | 13.76M | 10.95M | 32.1M | 29.6M | 35.8M |
| OpEx % of Revenue | - | 63.1% | 75.75% | 72.38% | 94.36% | 77.4% | 81.8% | 83.31% | 123.42% | 100.33% | 124.03% | 186.05% | 239.24% | 745.87% | - | - | - | - | - | 553.06% | 6226% | 3751.2% | 1180.14% | 465.36% | 105.51% | 748.95% | 87.46% | 97.61% | 321% | 121.81% | 166.51% |
| Selling, General & Admin | 77.7M | 115M | 152.31M | 199.94M | 304.42M | 408.33M | 463.31M | 323.62M | 227M | 134.55M | 111.37M | 101.05M | 79.35M | 121.25M | 57.79M | 22.56M | 17.09M | 15.25M | 15.23M | 19.45M | 13.27M | 10.58M | 6.99M | 30.89M | 23.66M | 33.26M | 8.73M | 4.62M | 8.4M | 7.3M | 34.6M |
| SG&A % of Revenue | - | 53.83% | 66.62% | 65.15% | 82.45% | 70.02% | 75.45% | 75.3% | 99.03% | 74.29% | 85.62% | 123.6% | 146.39% | 460.12% | - | - | - | - | - | 264.15% | 2654% | 2115.4% | 686.82% | 419.36% | 36.12% | 666.09% | 55.47% | 41.18% | 84% | 30.04% | 160.93% |
| Research & Development | 18.31M | 19.81M | 20.87M | 22.22M | 30.41M | 29.31M | 38.96M | 34.39M | 55.9M | 47.16M | 49.98M | 51.06M | 50.33M | 72.75M | 58.96M | 21.6M | 28.01M | 17.84M | 12.95M | 12.11M | 17.19M | 8.92M | 3.48M | 5.44M | 6.22M | 4.14M | 5.75M | 6.33M | 19.8M | 19.8M | 0 |
| R&D % of Revenue | - | 9.27% | 9.13% | 7.24% | 8.24% | 5.03% | 6.34% | 8% | 24.39% | 26.04% | 38.42% | 62.46% | 92.85% | 276.08% | - | - | - | - | - | 164.4% | 3437.2% | 1784% | 342.28% | 73.89% | 9.49% | 82.86% | 36.54% | 56.44% | 198% | 81.48% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 13.53M | 13.72M | 104K | 0 | -326K | 74K | -482K | -9K | -503K | -1.15M | -427K | 0 | 0 | -2.16M | 0 | 9.17M | 1.21M | 676K | -510K | -2.05M | 39.24M | 0 | -1K | -1K | 2.6M | 2.5M | 1.2M |
| Operating Income | -24.6M | -13.94M | -91.8M | -56.62M | -105.87M | 10.5M | -19.66M | -24.28M | -108.22M | -45.55M | -65.63M | -98.22M | -95.95M | -182.11M | -116.75M | -44.35M | -44.63M | -30.38M | -28.18M | -31.92M | -31.16M | -18.91M | -11.09M | -38.82M | -32.66M | -5.08M | -2.65M | -7.13M | -10.5M | -8.1M | -18.3M |
| Operating Margin % | -13.97% | -6.53% | -40.15% | -18.45% | -28.68% | 1.8% | -3.2% | -5.65% | -47.22% | -25.15% | -50.45% | -120.14% | -177.03% | -691.08% | - | - | - | - | - | -433.46% | -6232.2% | -3781.6% | -1090.66% | -527.1% | -49.86% | -101.7% | -16.81% | -63.58% | -105% | -33.33% | -85.12% |
| Operating Income Growth % | - | 84.81% | -62.14% | 46.52% | -1108.08% | 153.43% | 19.05% | 77.57% | -137.57% | 30.58% | 33.19% | -2.36% | 47.31% | -55.98% | -163.25% | 0.62% | -46.91% | -7.79% | 11.73% | -2.45% | -64.8% | -70.47% | 71.43% | -18.86% | -543.21% | -91.98% | 62.91% | 32.08% | -29.63% | 55.74% | -497.83% |
| EBITDA | -21.98M | -10.91M | -88.88M | -53.65M | -102.77M | 13.36M | -17.62M | -23.42M | -107.56M | -44.85M | -64.84M | -97.41M | -95.11M | -181.21M | -116.3M | -44.25M | -44.53M | -29.79M | -27.93M | -31.54M | -30.37M | -18.1M | -10.34M | -38.15M | -24.37M | 16.14M | -223K | -4.81M | -7.9M | -5.6M | -17.1M |
| EBITDA Margin % | -12.49% | -5.11% | -38.88% | -17.48% | -27.84% | 2.29% | -2.87% | -5.45% | -46.92% | -24.76% | -49.85% | -119.15% | -175.48% | -687.69% | - | - | - | - | - | -428.21% | -6073.2% | -3619.6% | -1016.52% | -517.99% | -37.2% | 323.27% | -1.42% | -42.9% | -79% | -23.05% | -79.53% |
| EBITDA Growth % | 76.44% | 87.72% | -65.67% | 47.8% | -869.32% | 175.83% | 24.78% | 78.23% | -139.83% | 30.84% | 33.43% | -2.42% | 47.51% | -55.81% | -162.83% | 0.62% | -49.44% | -6.69% | 11.45% | -3.86% | -67.79% | -75.06% | 72.9% | -56.56% | -250.97% | 7338.12% | 95.37% | 39.08% | -41.07% | 67.25% | -405.36% |
| D&A (Non-Cash Add-back) | 2.62M | 3.03M | 2.92M | 2.96M | 3.1M | 2.86M | 2.04M | 859K | 669K | 708K | 783K | 812K | 844K | 892K | 449K | 100.43K | 99.97K | 582K | 254.19K | 386K | 795K | 810K | 754K | 671K | 8.29M | 21.22M | 2.42M | 2.32M | 2.6M | 2.5M | 1.2M |
| EBIT | -20.52M | -36.04M | -77.19M | -53.66M | -103.79M | 11.42M | -14.76M | -15.86M | -107.3M | -45.05M | -57.31M | -98.11M | -40.62M | -135.51M | -152.77M | -66.89M | -250M | -55.74M | -20.12M | -38.82M | -30.63M | -20.1M | 11.65M | -38.82M | -33.74M | -5.08M | -2.65M | -7.13M | -10.5M | -8.1M | -18.3M |
| Net Interest Income | 10.41M | 10.85M | 13.4M | 11.86M | 2.8M | 1.09M | 2.3M | 1.87M | -7.8M | -9.34M | -18.44M | -20.05M | -18.48M | -33.84M | -17.55M | 230K | 34K | -7.45M | 7.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 10.41M | 10.85M | 13.4M | 11.86M | 2.82M | 1.22M | 4.9M | 8.5M | 1.07M | 429K | 234K | 0 | 0 | 343K | 544K | 231K | 53K | 198.94K | 9.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 7K | 7K | 8K | 15K | 129K | 2.6M | 6.63M | 8.87M | 9.77M | 18.68M | 20.05M | 18.48M | 34.18M | 18.09M | 1K | 19K | 8.23M | 2.14M | 6.46M | 0 | 1.8M | 0 | 0 | 29.46M | 0 | 0 | 0 | 24.4M | 800K | 0 |
| Other Income/Expense | 7.47M | -22.11M | 14.6M | 2.95M | 2.06M | 789K | 2.4M | 1.8M | -8.12M | -9.26M | -10.76M | -20.07M | 36.75M | 12.69M | -53.32M | -22.73M | -205.4M | -29.36M | 7.58M | -7.08M | 3.44M | -497K | 222K | 12.24M | -883K | 366K | 525K | -1.63M | -5.5M | -3.2M | 1.6M |
| Pretax Income | -17.13M | -36.05M | -77.2M | -53.67M | -103.81M | 11.29M | -17.25M | -22.48M | -116.35M | -55.41M | -76.38M | -118.29M | -59.2M | -169.42M | -170.95M | -66.89M | -250.09M | -59.74M | -20.96M | -39M | -27.52M | -21.26M | -10.39M | -26.58M | -33.55M | -4.71M | -2.12M | -8.76M | -16M | -11.3M | -16.7M |
| Pretax Margin % | -9.73% | -16.87% | -33.77% | -17.49% | -28.12% | 1.94% | -2.81% | -5.23% | -50.76% | -30.59% | -58.72% | -144.69% | -109.22% | -642.94% | - | - | - | - | - | -529.57% | -5503.8% | -4251.4% | -1021.24% | -360.9% | -51.21% | -94.37% | -13.47% | -78.1% | -160% | -46.5% | -77.67% |
| Income Tax | 2.01M | 2.75M | 4.98M | 5.44M | 2M | 3.56M | 745K | 164K | 96K | 13.05M | 9.97M | -3.09M | -2.84M | -3.19M | 9.12M | 2.52M | -501K | -440K | -674K | -837K | -799K | -698K | 7.33M | -7.36M | 3.54M | 412K | 342K | -27K | 100K | 600K | -1.1M |
| Effective Tax Rate % | -11.74% | -7.63% | -6.45% | -10.14% | -1.92% | 31.55% | -4.32% | -0.73% | -0.08% | -23.55% | -13.05% | 2.61% | 4.79% | 1.89% | -5.33% | -3.76% | 0.2% | 0.74% | 3.22% | 2.15% | 2.9% | 3.28% | -70.6% | 27.67% | -10.55% | -8.74% | -16.13% | 0.31% | -0.63% | -5.31% | 6.59% |
| Net Income | -19.14M | -38.8M | -82.18M | -59.11M | -105.8M | 7.73M | -18M | -22.64M | -116.44M | -67.86M | -86.35M | -115.2M | -56.36M | -166.23M | -179.18M | -69.42M | -249.52M | -59.32M | -20.02M | -38.17M | -26.92M | -20.55M | 3.23M | -19.22M | -37.08M | -4.76M | 2.54M | 4.37M | -28.8M | -7.7M | -15.6M |
| Net Margin % | -10.87% | -18.16% | -35.95% | -19.26% | -28.66% | 1.33% | -2.93% | -5.27% | -50.8% | -37.47% | -66.38% | -140.91% | -103.99% | -630.82% | - | - | - | - | - | -518.22% | -5384% | -4109.4% | 317.5% | -261.02% | -56.61% | -95.33% | 16.15% | 38.96% | -288% | -31.69% | -72.56% |
| Net Income Growth % | 77.79% | 52.79% | -39.03% | 44.13% | -1468.91% | 142.94% | 20.51% | 80.55% | -71.58% | 21.41% | 25.05% | -104.39% | 66.09% | 7.23% | -158.11% | 72.18% | -320.66% | -196.27% | 47.54% | -41.78% | -31.02% | -736.33% | 116.8% | 48.16% | -679.08% | -287.33% | -41.85% | 115.17% | -274.03% | 50.64% | -480.49% |
| Net Income (Continuing) | -19.14M | -38.8M | -82.18M | -59.11M | -105.8M | 7.73M | -18M | -22.64M | -116.44M | -68.59M | -86.35M | -115.2M | -56.36M | -166.23M | -180.12M | -69.42M | -249.52M | -59.3M | -20.27M | -38.17M | -26.72M | -20.55M | -17.72M | -19.22M | -37.08M | -5.12M | -2.46M | -8.73M | -16.1M | -11.9M | -15.6M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.92 | -1.80 | -4.00 | -3.00 | -5.20 | 0.38 | -1.00 | -1.32 | -7.80 | -5.00 | -8.20 | -16.60 | -7.20 | -25.60 | -24.80 | -10.60 | -49.80 | -28.00 | -18.20 | -81.60 | -67.00 | -88.00 | 23.20 | -224.80 | -796.80 | -22.80 | 60.40 | 582.80 | -3840.00 | -1040.00 | -2200.00 |
| EPS Growth % | 74.94% | 55% | -33.33% | 42.31% | -1468.42% | 138% | 24.24% | 83.08% | -56% | 39.02% | 50.6% | -130.56% | 71.88% | -3.23% | -133.96% | 78.71% | -77.86% | -53.85% | 77.7% | -21.79% | 23.86% | -479.31% | 110.32% | 71.79% | -3394.74% | -137.75% | -89.64% | 115.18% | -269.23% | 52.73% | -454.84% |
| EPS (Basic) | - | -1.80 | -4.00 | -3.00 | -5.20 | 0.39 | -0.94 | -1.32 | -7.80 | -5.00 | -8.20 | -16.60 | -6.40 | -20.60 | -24.80 | -10.60 | -49.80 | -28.00 | -18.20 | -81.60 | -67.00 | -92.60 | 34.40 | -224.80 | -796.80 | -101.20 | 128.40 | 582.80 | -3843.80 | -1040.00 | -2200.00 |
| Diluted Shares Outstanding | 20.82M | 20.75M | 20.55M | 20.38M | 20.06M | 20.12M | 19.09M | 17.13M | 14.86M | 13.53M | 10.59M | 9.03M | 8.69M | 8.35M | 7.2M | 6.51M | 5.01M | 2.12M | 1.1M | 468.45K | 401.6K | 202.05K | 138.63K | 85.55K | 46.69K | 209.28K | 42.1K | 7.5K | 7.5K | 7.4K | 7.09K |
| Basic Shares Outstanding | 20.82M | 20.75M | 20.55M | 19.7M | 20.06M | 19.8M | 18M | 17.13M | 14.86M | 13.53M | 10.53M | 8.98M | 8.69M | 8.05M | 7.2M | 6.51M | 5.01M | 2.12M | 1.1M | 468.45K | 401.6K | 202.05K | 89.7K | 85.55K | 46.69K | 47.03K | 7.49K | 7.5K | 7.49K | 7.4K | 7.09K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying AMRN stock.
For fiscal year 2025, Amarin Corporation plc (AMRN) reported total revenue of $213.6M. This represents a 893.7% increase compared to $21.5M in 1996.
Amarin Corporation plc (AMRN) reported a net loss of $38.8M for the fiscal year ending 2025.
Amarin Corporation plc (AMRN) reported an operating income of $-13.9M, resulting in an operating profit margin of -6.5%. This margin reflects the operational efficiency of the business before interest and taxes.
Amarin Corporation plc (AMRN) generated $120.9M in gross profit for the year, representing a gross profit margin of 56.6%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Revenue contraction and losses
Metrics are mathematically derived from official filings.
Revenue Stabilizing After Sharp Decline
Based on reported quarterly figures, AMRN's revenue fell from $72.7M in 2025Q2 to $39.5M in 2026Q3, a decline of roughly 46% that suggests sustained erosion rather than a one-time timing effect.
The year-over-year growth rates have been negative in most recent quarters, with 2026Q2 down 42.0% and 2026Q3 down 20.4%, indicating the top line is still contracting even as the rate of decline appears to moderate. The 2025Q2 peak was likely inflated by a one-time or favorable pricing period, making the trailing comparison base unusually high. Investors should monitor whether the sequential stabilization near $40-45M per quarter holds, as further weakness would signal structural demand loss.
Gross Margin Recovering From Lows
As reported in the quarterly income statements, AMRN's gross margin moved from negative 15.4% in 2024Q4 to 40.9% in 2026Q3, a recovery that appears driven by cost normalization rather than revenue expansion.
The gross margin trajectory is volatile, peaking at 69.2% in 2025Q2 before compressing to 35.5% in 2026Q2, which suggests the gross profit line is sensitive to period-specific cost or inventory items. The current 40.9% level remains well below the 2025Q2 peak and below peer gross margins in the 77-92% range for specialty pharma names. Warrants further investigation into whether the margin rebound reflects durable cost structure improvement or temporary factors.
Operating Costs Outpace Gross Profit
Based on the reported figures, AMRN's SG&A of $14.3M in 2026Q3 consumed roughly 36% of gross profit, leaving operating losses in most recent quarters despite positive gross profit.
Operating income has remained negative across all ten reported quarters except 2024Q2 is near breakeven, indicating that the cost base has not scaled down in line with the revenue decline. SG&A remained elevated at $19.7M to $38.7M in 2025 and 2026 periods, showing limited expense flexibility. This pattern suggests negative operating leverage, where shrinking revenue compresses margins faster than costs can be reduced.
Net Income Swings Driven by Non-Operating Items
According to the reported income statements, AMRN's net income in 2026Q3 was $245K despite an operating loss of $2.4M, a gap that suggests non-operating items materially affected the bottom line.
The divergence between operating income and net income in several quarters, such as 2024Q4 where net loss was close to operating loss, points to items below the operating line such as interest or other income. Stock-based compensation has been material at $1.4M to $6.0M per quarter in several periods, and a negative SBC figure in 2025Q4 warrants review. Earnings quality appears weak given the frequent reliance on non-operating items to shift reported results.
R&D Lean Relative to SG&A Burden
As reported in the financial statements, AMRN's R&D spending of $4.2M to $6.0M per quarter represents a small fraction of total operating costs, while SG&A has absorbed most of the expense base.
SG&A consistently exceeds R&D by a wide margin, with SG&A at $14.3M against R&D of $4.2M in 2026Q3, indicating a commercially oriented cost structure rather than a research-led one. This mix may suggest the company is managing for commercial cash generation, though it also raises questions about the sustainability of the product pipeline. Investors should monitor whether SG&A is reduced further in line with revenue or whether it remains a fixed burden.
Losses Persist Despite Recent Stabilization
Based on reported quarterly results, the case against AMRN rests on continued revenue decline and operating losses in most periods, with the recent quarterly profit appearing to rely on non-operating or one-time effects.
The bear argument centers on the fact that revenue has declined for multiple consecutive quarters and that the single profitable quarter in 2026Q3 reflected a net income of only $245K against an operating loss. Negative net margins in most periods, including -37.4% in 2025Q1 and -78.0% in 2024Q4, suggest the business has not yet demonstrated a durable path to profitability. Investors should be cautious about extrapolating the recent stabilization without evidence of sustained operating income.